Long-term interferon monotherapy reduces the risk of HCV-associated hepatocellular carcinoma.
Takeyasu M; Akuta N; Suzuki F; Seko Y; Kawamura Y; Sezaki H; Suzuki Y; Hosaka T; Kobayashi M; Kobayashi M; Arase Y; Ikeda K; Kumada H; Journal Of Medical Virology, 2012, vol. 84, issue 8, p 1199, ISSN 10969071. ISBN 10969071.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef